Publications by authors named "Jennifer Gao"

Claim this Profile
P
Project 5 in 5: Paving the Way for Pragmatism in Clinical Oncology Trials.
Steven Clark Cunningham, Kelly Norsworthy, Jennifer J Gao, Paul G Kluetz, Donna R Rivera

JCO Oncol Pract· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Stage II and III High-Risk Early Breast Cancer Treatment Setting.
Jennifer J Gao, Tatiana M Prowell, Haley Gittleman, Joyce Cheng, Mallorie Fiero, Tingting Gao

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and Anatomical Changes of Acute Solar Retinopathy Investigated With Electroretinography and Optical Coherence Tomography: A Case Report.
Korolos Sawires, Bonnie He, Jeff Locke, Jennifer Gao, R Rishi Gupta

Cureus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.
Sundeep Agrawal, Clara Lee, William F Pierce, Elizabeth Everhart, Adriene King-Ducre, Jennifer J Gao

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflections and Roadmaps: Career Development beyond the FDA-AACR Oncology Educational Fellowship.
Timil Patel, Chris Chen, Samer Al Hadidi, Yasmin Kadry, Rajeshwari Sridhara, Jennifer Gao

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.
Jennifer J Gao, Christy L Osgood, Zhou Feng, Erik W Bloomquist, Shenghui Tang

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Therapies for Asian Americans, Native Hawaiians, and Other Pacific Islanders With Cancer: OCE's Project ASIATICA.
Jennifer J Gao, Richard Pazdur, Tamy Kim

JCO Oncol Pract· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of the Oncology Center of Excellence Patient-Friendly Language Glossary of Oncology Clinical Trial Terms.
Danielle Krol, Janice Kim, Jennifer Gao, Laleh Amiri-Kordestani, Julia A Beaver

Oncologist· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deoxycholic Acid for Dercum Disease: Repurposing a Cosmetic Agent to Treat a Rare Disease.
Channi Silence, Shauna M Rice, Andrew Liteplo, Kathleen McFadden, Nour Al Jalbout, Jennifer Gao

Cutis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Five Criteria for Evaluating Glaucomatous Visual Fields.
Herman Stubeda, Jack Quach, Jennifer Gao, Lesya M Shuba, Marcelo T Nicolela

Am J Ophthalmol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reexamination of Patient Autonomy and Prior Therapies in Oncology Clinical Trial Eligibility Criteria.
Jennifer J Gao, Richard Pazdur, Julia A Beaver

JAMA Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration Analysis of Patient-Reported Diarrhea and Its Impact on Function and Quality of Life in Patients Receiving Treatment for Breast Cancer.
Ting-Yu Chen, Bellinda L King-Kallimanis, Lyna Merzoug, Erica G Horodniceanu, Mallorie H Fiero, Jennifer J Gao

Value Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Technology to Enhance Cancer Clinical Trial Participation.
Rudene Mercer Haynes, S Joseph Sirintrapun, Jennifer Gao, Andrew J McKenzie

Am Soc Clin Oncol Educ Book· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review.
Shaily Arora, Preeti Narayan, Gwynn Ison, Tara Berman, Daniel L Suzman, Jennifer J Gao

Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.
Shaily Arora, Preeti Narayan, Christy L Osgood, Suparna Wedam, Tatiana M Prowell, Jennifer J Gao

Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis.
Jennifer J Gao, Joyce Cheng, Tatiana M Prowell, Erik Bloomquist, Shenghui Tang

Lancet Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.
Jeremy Mason, Yutao Gong, Laleh Amiri-Kordestani, Suparna Wedam, Jennifer J Gao

JCO Clin Cancer Inform· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, Laura L Fernandes, Emily Li

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer.
Jennifer J Gao, Christy L Osgood, Yutao Gong, Hui Zhang, Erik W Bloomquist

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs.
Paul G Kluetz, Patricia Keegan, George D Demetri, Katherine Thornton, Joohee Sul, Jennifer J Gao

Clin Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. Food and Drug Administration: Initial Experience with the Real-Time Oncology Review Program.
R Angelo de Claro, Jennifer J Gao, Tamy Kim, Paul G Kluetz, Marc R Theoret

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, Tara Berman, Preeti Narayan, Jennifer J Gao

Oncologist· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Oncology Center of Excellence During COVID-19-Working for Patients With Cancer.
Jennifer J Gao, Richard Pazdur

JAMA Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Oncology Center of Excellence Review Processes and Tools.
Jennifer J Gao, Paul G Kluetz, Richard Pazdur

Clin Pharmacol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy - Authors' reply.
Jennifer J Gao, Joyce Cheng, Julia A Beaver, Tatiana M Prowell

Lancet Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis